AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...

Scientists at EMBL Grenoble and the European Synchrotron Radiation Facility (ESRF) have developed a new method for using in ...

GS E&R has commercialized a new solution for predicting wind power intermittency. The breakthrough, according to the ...

Oppenheimer analyst Leland Gershell maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report) on November 11 and set a ...

S4V2 will be tested for safety and preliminary efficacy in approximately 120 healthy Shigella -naïve participants aged 18 to 50 years at three sites in the United States. The study, sponsored and ...

Iovance Biotherapeutics is a biopharmaceutical company that develops and commercializes cancer immunotherapy products. In February 2024, Amtagvi, also known as lifileucel, became the first FDA ...

Analysts anticipate Rockwell Medical to report an earnings per share (EPS) of $0.01. The market awaits Rockwell Medical's ...

coverage and reimbursement negotiations with third party payors for PTC's products or product candidates that PTC commercializes or may commercialize in the future; expectations with respect to ...

Overview: Taysha Gene Therapies, Inc. is a gene therapy company that develops and commercializes adeno-associated virus-based ...

Nuwellis (NASDAQ:NUWE – Get Free Report) is set to announce its earnings results before the market opens on Monday, November ...